Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 0.0022M
March 31, 2026 -0.0008M
December 31, 2025 0.002M
September 30, 2025 0.0005M
June 30, 2025 -0.0092M
March 31, 2025 -0.0317M
December 31, 2024 -0.0129M
September 30, 2024 -0.0165M
June 30, 2024 -0.0281M
March 31, 2024 -0.0123M
December 31, 2023 -0.0038M
September 30, 2023 -0.0048M
June 30, 2023 -0.0168M
March 31, 2023 -0.0517M
December 31, 2022 -0.0455M
September 30, 2022 -0.0329M
June 30, 2022 0.1645M
March 31, 2022 -0.0409M
December 31, 2021 0.1538M
September 30, 2021 -0.1174M
June 30, 2021 0.3538M
March 31, 2021 -0.0157M
December 31, 2020 0.0302M
September 30, 2020 -0.0209M
June 30, 2020 0.0523M
Date Value
March 31, 2020 -0.0158M
December 31, 2019 -0.0727M
September 30, 2019 -0.0061M
June 30, 2019 -0.0035M
March 31, 2019 -0.046M
December 31, 2018 -0.0442M
September 30, 2018 0.0158M
June 30, 2018 -0.0305M
March 31, 2018 0.0246M
December 31, 2017 0.1145M
September 30, 2017 -0.0001M
June 30, 2017 -0.1009M
March 31, 2017 -0.0273M
December 31, 2016 -0.1088M
September 30, 2016 -0.0434M
June 30, 2016 -0.0147M
March 31, 2016 -0.0775M
December 31, 2015 -0.2404M
September 30, 2015 -0.1151M
June 30, 2015 -0.188M
March 31, 2015 -0.3093M
December 31, 2014 -0.347M
September 30, 2014 -0.4147M
June 30, 2014 -0.2268M
March 31, 2014 -0.1793M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Medifast, Inc. 1.697M
Integrated BioPharma, Inc. -1.194M
BioForce Nanosciences Holdings, Inc. -0.027M
SkyTech Orion Global Corp. -0.16M
Nevis Brands, Inc. 0.0481M